The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Cancer Recurrence Surveillance Strategies

Risk-adapted follow-up plans for early detection of locoregional and distant disease relapse

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Onkoloji department. Book Appointment →

What is Cancer Recurrence Surveillance Strategies?

Recurrence surveillance is most intensive during the first two to three years for most solid tumors when the relapse risk is highest. Breast and colorectal cancer surveillance is well validated and includes physical examination, mammography or colonoscopy, and selected serum markers such as carcinoembryonic antigen.

Imaging modality and frequency depend on tumor histology, stage, and treatment. Computed tomography, magnetic resonance imaging, positron emission tomography, and ultrasound are selected to detect actionable recurrence sites. Routine intensive imaging without symptom indication does not improve survival in many cancers and may cause harm through incidental findings.

Patient-reported outcomes and survivorship needs are integral to surveillance. Physical, psychosocial, sexual, and financial concerns are addressed through structured visits with primary care, oncology, and specialty follow-up. Survivorship care plans, second-cancer screening, and lifestyle counseling complete a contemporary surveillance program.

Symptoms

Asymptomatic patient on surveillance schedule
New persistent symptom in survivor
Tumor marker elevation
Imaging finding requiring evaluation
Patient-reported quality of life concerns

Risk Factors

Recently completed curative treatment
High-risk pathologic features
Hereditary cancer syndrome
Adverse molecular profile
Continued environmental exposure

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • When new persistent symptoms appear
  • When scheduled visit is due
  • When tumor marker rises
  • When imaging is abnormal
  • When new psychosocial concern emerges

Treatment Methods

01
Risk-adapted clinical examination schedule
02
Tumor-specific imaging modality and frequency
03
Selected serum tumor markers
04
Endoscopy or mammography per guidelines
05
Patient-reported outcome assessment
06
Survivorship care plan and lifestyle counseling
07
Coordinated multidisciplinary follow-up

Which Department to Visit?

You can visit our Onkoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Onkoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.